Quetiapine vs Olanzapine: Metabolic and Clinical Considerations

Primary Advantages of Quetiapine

The American College of Psychiatry recommends quetiapine over olanzapine when metabolic risk is a major concern, as quetiapine causes significantly less weight gain and metabolic dysfunction 1
Olanzapine consistently ranks among the worst antipsychotics for metabolic effects, alongside clozapine, making quetiapine a preferable option for patients with metabolic risk factors 1
Guidelines recommend adjunctive metformin to mitigate metabolic harm when antipsychotics with poor cardiometabolic profiles like olanzapine are used, but this recommendation is less emphasized for quetiapine 1

Quetiapine is explicitly recommended as a switch option when akathisia occurs with other antipsychotics, making it a rational choice when extrapyramidal symptoms are problematic 1, 2

Combining quetiapine and olanzapine substantially amplifies drowsiness and fall risk, highlighting the need for careful consideration when co-prescribing these agents 3

Baseline assessment must include BMI, waist circumference, blood pressure, HbA1c, glucose, lipids, prolactin, liver function, renal function, full blood count, and ECG, with regular monitoring thereafter 1
Fasting glucose should be rechecked at 4 weeks following initiation, with weekly monitoring for 6 weeks of BMI, waist circumference, and blood pressure 1
All measures should be repeated at 3 months and annually thereafter to ensure ongoing monitoring of metabolic parameters 1